Patent

Patents

Invention: “Isolated microorganism strain Lactobacillus plantarum TENSIA®DSM 21380 as antimicrobial and antihypertensive probiotic, food product and composition comprising said microorganism and use of said microorganism for preparation of antihypertensive medicine and method for suppressing pathogens and nonstarter lactobacilli in food product”

Patents:

  • Estonian patent EE05340, granted 16.08.2010, “Isolated microorganism strain Lactobacillus plantarumTensia DSM 21380 as antimicrobial and antihypertensive probiotic, food product and composition comprising said microorganism and use of said microorganism for preparation of antihypertensive medicine and method for suppressing pathogens and nonstarter lactobacilli in food product”.
  • Russian patent RU2477750, granted 20.03.2013, “Изолированный штамм микроорганизма Lactobacillus plantarum Tensia DSM 21380 как противомикробный и гипотензивный пробиотик, продукт питания и композиция, содержащая упомянутый микроорганизм, и применение упомянутого микроорганизма для получения гипотензивного лекарственного средства, способ подавления патогенов и побочных лактобактерий в продукте питания“.
  • European patent EP2309870,granted 04.05.2012, “Isolated microorganism strain Lactobacillus plantarum Tensia DSM 21380 as antimicrobial and antihypertensive probiotic, food product and composition comprising said microorganism and use of said microorganism for preparation of antihypertensive medicine and method for suppressing pathogens and non-starter lactobacilli in food product”.

EP2309870 is validated in:

  • United Kingdom  GP/EP2309870
  • Sweden SE/EP2309870
  • Germany  DE/EP2309870 (60 2009 007 496.2)
  • France  FR/EP2309870
  • Finland  FI/EP2309870
  • Czech  CZ/EP2309870
  • Poland  PL/EP2309870
  • Hungary  HU/EP2309870
  • Lithuania  LT/EP2309870
  • Latvia  LV/EP2309870
  • Korean patentKR10-1587195, granted 14.01.2016, 항균 및 항고혈압 프로바이오틱인 단리된 미생물 균주 락토바실러스 플란타룸 텐시아 DSM 21380과, 이 미생물을 포함하는 식품과 조성물 및 항고혈압제의 제조를 위한 이 미생물의 용도와, 식품에서 병원체 및 논-스타터 락토바실러스를 억제하기 위한 방법 („Isolated microorganism strain Lactobacillus plantarum Tensia DSM 21380 as antimicrobial and antihypertensive probiotic, food product and composition comprising said microorganism and use of said microorganism for preparation of antihypertensive medicine and method for suppressing pathogens and non-starter lactobacilli in food product“).

 

Invention: “Isolated Lactobacillus plantarum strain INDUCIA® DSM 21379 as probiotic that enhances natural immunity and food products and medicinal preparations comprising it”

Patents:                                 

  • Estonian patent EE05341, granted 16.08.2010, “Isolated Lactobacillus plantarum strain INDUCIA® DSM 21379 as probiotic that enhances natural immunity and food products and medicinal preparations comprising it”.
  • Russian patent RU2486234, granted 27.06.2013,  “Изолированный штамм микроорганизмаLactobacillus Plantarum Inducia DSM 21379 в качестве пробиотика, усиливающего врожденный иммунитет организма, продукт и композиция, содержащие упомянутый микроорганизм, и применение упомянутого микроорганизма для изготовления лекарственного средства, которое усиливает клеточный иммунитет”.                          
  • European patent EP2288360, granted 14.12.2011, “Isolated Lactobacillus plantarum strain Inducia DSM 21379 as probiotic that enhances natural immunity and food products and medicinal preparations comprising it”.

EP2288360 is validated in:

  • United Kingdom GB/EP2288360
  • Sweden  SE/EP2288360
  • Germany  DE/EP2288360 (60 2009 004 223.8)
  • France  FR/EP2288360
  • Finland  FI/EP2288360
  • Denmark  DK/EP2288360
  • Poland  PL/EP2288360
  • Lithuania LT/EP2288360
  • Latvia  LV/EP2288360
  • Korean patent KR10-1595042, granted 11.02.2016, “자연 면역을 증가시키는 프로바이오틱인 단리된 락토바실러스 플란타룸 균주 인듀시아 DSM 21379와, 이를 포함하는 식품과 의약적 제제 (“Isolated Lactobacillus plantarum strain Inducia DSM 21379 as probiotic that enhances natural immunity and food products and medicinal preparations comprising it”).

 

Invention „Lactobacillus plantarum INDUCIA® strain DSM 21379 as hypocholesterolemic agent and antimicrobial agent against Clostridium Difficile”

Pending patent applications:

  • Estonian Patent Application EE201400038, filed 31.10.2014, “Composition comprising hypocholesterolemic probiotic microorganism strain Lactobacillus plantarum Inducia DSM 21379 for use in preventing cardiovascular disorders”
  • International Patent Application PCT/EE2014000007, filed 31.10.2014 “Lactobacillus plantarum INDUCIA strain DSM 21379 as hypocholesterolemic agent and antimicrobial agent against Clostridium Difficile”
  • USA patent application US15132286, filed 19.04.2016, “Lactobacillus plantarum Inducia DSM 21379 as enhancer of cellular immunity, hypocholesterolemic and anti-oxidative agent and antimicrobial agent against Clostridium difficile”.

 

Invention: “Isolated microorganism strains Lactobacillus plantarum MCC1 DSM 23881 and Lactobacillus gasseri MCC2 23882 and their use”

Patents:

  • Estonian patent EE05721, granted 15.08.2014, „Isolated microorganism strain plantarum MCC1 DSM 23881 and its use”
  • Estonian patent EE05750, granted 15.06.2015, “Isolated microorganism strain Lactobacillus gasseri MCC2 DSM 23882 and its use”
  • European patent EP2678419, granted 23.09.2015, “Isolated microorganism strain Lactobacillus plantarum MCC1 DSM 23881 and its use”. EP2678419 is validated in:
    • Ireland IE/EP2678419
    • Germany  DE/ EP2678419
    • France  FR/ EP2678419
    • Finland  FI/ EP2678419
    • Serbia  RS/ EP2678419
    • Switzerland  CH/ EP2678419
    • Lithuania LT/ EP2678419
    • Latvia  LV/ EP2678419
    • United Kingdom GB/ EP2678419
  • European patent  EP2966164, granted 19.04.2017, “Isolated microorganism strain Lactobacillus gasseri MCC2 DSM 23882 and its use”.

EP2966164 is validated in:

  • Ireland IE/EP2966164
  • Germany  DE/EP2966164
  • France  FR/EP2966164
  • Switzerland CH/EP2966164
  • United Kingdom GB/EP2966164
  • Korean Patent KR10-1586778, granted 13.01.2016, “분리된 미생물 균주 락토바실러스 플란타룸 MCC1 DSM 23881 및 락토바실러스 가서리” MCC2 DSM 23882와 그의 용도 („Isolated microorganism strains Lactobacillus plantarum MCC1 DSM 23881 and Lactobacillus gasseri MCC2 DSM 23882 and their use)”.
  • Chinese patent CN1996956, granted 23.03.2016, “Isolated microorganism strains Lactobacillus plantarumMCC1 DSM 23881 and Lactobacillus gasseri MCC2 23882 and their use”.
  • Japan Patent JP5785275, granted 31.07.2015, “Isolated microorganism strains Lactobacillus plantarum MCC1 DSM 23881 and Lactobacillus gasseri MCC2 23882 and their use”.
  • Russian Patent RU2603059, granted 20.11.2016, “Изолированные штаммы микроорганизмов Lactobacillus plantarum MCC1 DSM 23881 и Lactobacillus gasseri MCC2 DSM 23882 и их применение” (“Isolated microorganism strains Lactobacillus plantarum MCC1 DSM 23881 and Lactobacillus gasseri MCC2 23882 and their use”).

Pending Patent Applications:

  • Chinese Patent Application CN201610114800.5, filed 13.07.2016 “Isolated microorganism strain Lactobacillus gasseri MCC2 23882 and its use”.

 

Invention: “Microorganism Lactobacillus plantarumTAK 59 NCIMB42150 and its use”

Patents:

  • Estonian patent EE05746granted 15.05.2015, ”Microorganism Lactobacillus plantarum TAK 59 NCIMB42150 and use thereof”.
  • European patent EP3027734, granted 25.10.2017, “Isolated microorganism strain Lactobacillus plantarum TAK 59 NCIMB42150 and its use.

Pending Patent Applications:

  • Japanese patent application JP2016-530353, filed 01.02.2016, “Microorganism Lactobacillus plantarum TAK 59 NCIMB42150 and its use”.
  • Russian patent application RU2016107018,filed 26.02.2016 “Изолированный штамм микроорганизма Lactobacillus plantarum TAK 59 NCIMB42150 и его применение”.
  • International patent application  PCT/EE2014/000003, filed 30.07.2014, “Microorganism Lactobacillus plantarum TAK 59 NCIMB42150 and its use”.

 

Invention: “Microorganism Lactobacillus brevisTAK 124-1 NCIMB42149 and its use”

Patents:

  • Estonian patent EE05756,granted 16.11.2015, “Isolated microorganism strain Lactobacillus brevis TAK 124-1 NCIMB42149 and use thereof”.

Pending Patent Applications:

  • International patent application PCT/EE2015/000001,filed 13.02.2015,  Microorganism Lactobacillus brevis TAK 124-1 NCIMB42149 and its use”.

 

Invention: “A method for identifying of cows, sires and bull dams that produce milk with modified coagulation properties”

  • Estonian patent  EE05659, granted 17.06.2013, “Method of identifying of cows, sires and bull dams producing milk with modified coagulation properties”.
  • Russian patent RU2409942, granted 27.01.2011, “Способ идентификации крупного рогатого скота, производящего молоко с модифицированными коагуляционными свойствами”.
  • European patent EP2053914, granted 26.01.2011,“Method of identifying of cows, sires and bull dams producing milk with modified coagulation properties”.